Search research articles
Contact Us
Filters
Showing results (391-400 of 403) with videos related to
Page
of 41
Sort By:
The Journal of Clinical Investigation
|
June 24, 2020
FGFR4 regulates tumor subtype differentiation in luminal breast cancer and metastatic disease
Susana Garcia-Recio, Aatish Thennavan, Michael P East, et al.
BMC Genomics
|
April 29, 2006
The molecular portraits of breast tumors are conserved across microarray platforms
Zhiyuan Hu, Cheng Fan, Daniel S Oh, et al.
JAMA Oncology
|
January 18, 2024
Endocrine-Sensitive Disease Rate in Postmenopausal Patients With Estrogen Receptor-Rich/ERBB2-Negative Breast Cancer Receiving Neoadjuvant Anastrozole, Fulvestrant, or Their Combination: A Phase 3 Randomized Clinical Trial
Cynthia X Ma, Vera J Suman, Souzan Sanati, et al.
Science (New York, N.Y.)
|
July 21, 2018
VHL substrate transcription factor ZHX2 as an oncogenic driver in clear cell renal cell carcinoma
Jing Zhang, Tao Wu, Jeremy Simon, et al.
Zhonghua Yu Fang Yi Xue Za Zhi [Chinese Journal of Preventive Medicine]
|
June 19, 2009
[Mental health assessment among scattered residents after Wenchuan earthquake in Anxian, Sichuan province]
Shi-an Liu, Hang Zhou, Xian-feng Zhou, et al.
Zhonghua Yu Fang Yi Xue Za Zhi [Chinese Journal of Preventive Medicine]
|
June 19, 2009
[Public health situation and needs assessment after Wenchuan earthquake in Anxian, Sichuan province]
Xian-feng Zhou, Hang Zhou, Shi-an Liu, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 19, 2022
CALGB 40603 (Alliance): Long-Term Outcomes and Genomic Correlates of Response and Survival After Neoadjuvant Chemotherapy With or Without Carboplatin and Bevacizumab in Triple-Negative Breast Cancer
Jonathan H Shepherd, Karla Ballman, Mei-Yin C Polley, et al.
NPJ Breast Cancer
|
May 13, 2021
FOXA1 and adaptive response determinants to HER2 targeted therapy in TBCRC 036
Steven P Angus, Timothy J Stuhlmiller, Gaurav Mehta, et al.
Medrxiv : the Preprint Server for Health Sciences
|
September 5, 2025
Integration of Gene Expression and Digital Histology to Predict Treatment-Specific Responses in Breast Cancer
Frederick M Howard, James Dolezal, Hanna Hieromnimon, et al.
Journal of Translational Medicine
|
October 11, 2023
Prediction of clinically significant prostate cancer through urine metabolomic signatures: A large-scale validated study
Hsiang-Po Huang, Chung-Hsin Chen, Kai-Hsiung Chang, et al.
Page
of 41
Search research articles
Search
Showing results (391-400 of 403) with videos related to
Sort By:
Page
of 41
The Journal of Clinical Investigation
|
June 24, 2020
FGFR4 regulates tumor subtype differentiation in luminal breast cancer and metastatic disease
Susana Garcia-Recio, Aatish Thennavan, Michael P East, et al.
BMC Genomics
|
April 29, 2006
The molecular portraits of breast tumors are conserved across microarray platforms
Zhiyuan Hu, Cheng Fan, Daniel S Oh, et al.
JAMA Oncology
|
January 18, 2024
Endocrine-Sensitive Disease Rate in Postmenopausal Patients With Estrogen Receptor-Rich/ERBB2-Negative Breast Cancer Receiving Neoadjuvant Anastrozole, Fulvestrant, or Their Combination: A Phase 3 Randomized Clinical Trial
Cynthia X Ma, Vera J Suman, Souzan Sanati, et al.
Science (New York, N.Y.)
|
July 21, 2018
VHL substrate transcription factor ZHX2 as an oncogenic driver in clear cell renal cell carcinoma
Jing Zhang, Tao Wu, Jeremy Simon, et al.
Zhonghua Yu Fang Yi Xue Za Zhi [Chinese Journal of Preventive Medicine]
|
June 19, 2009
[Mental health assessment among scattered residents after Wenchuan earthquake in Anxian, Sichuan province]
Shi-an Liu, Hang Zhou, Xian-feng Zhou, et al.
Zhonghua Yu Fang Yi Xue Za Zhi [Chinese Journal of Preventive Medicine]
|
June 19, 2009
[Public health situation and needs assessment after Wenchuan earthquake in Anxian, Sichuan province]
Xian-feng Zhou, Hang Zhou, Shi-an Liu, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 19, 2022
CALGB 40603 (Alliance): Long-Term Outcomes and Genomic Correlates of Response and Survival After Neoadjuvant Chemotherapy With or Without Carboplatin and Bevacizumab in Triple-Negative Breast Cancer
Jonathan H Shepherd, Karla Ballman, Mei-Yin C Polley, et al.
NPJ Breast Cancer
|
May 13, 2021
FOXA1 and adaptive response determinants to HER2 targeted therapy in TBCRC 036
Steven P Angus, Timothy J Stuhlmiller, Gaurav Mehta, et al.
Medrxiv : the Preprint Server for Health Sciences
|
September 5, 2025
Integration of Gene Expression and Digital Histology to Predict Treatment-Specific Responses in Breast Cancer
Frederick M Howard, James Dolezal, Hanna Hieromnimon, et al.
Journal of Translational Medicine
|
October 11, 2023
Prediction of clinically significant prostate cancer through urine metabolomic signatures: A large-scale validated study
Hsiang-Po Huang, Chung-Hsin Chen, Kai-Hsiung Chang, et al.
Page
of 41